Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Applications of NSAIDs: Insight and Future Perspectives in Cardiovascular, Neurodegenerative, Diabetes and Cancer Disease Therapy
Edmundas Kaduševičius
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6637-6637
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Functionalized hybrid magnetic catalytic systems on micro- and nanoscale utilized in organic synthesis and degradation of dyes
Fatemeh Ganjali, Amir Kashtiaray, Simindokht Zarei-Shokat, et al.
Nanoscale Advances (2022) Vol. 4, Iss. 5, pp. 1263-1307
Open Access | Times Cited: 49
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Rahul Mallick, Sanjay Basak, Parimal Chowdhury, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 104-104
Open Access | Times Cited: 1
Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment
M. Helena Vasconcelos, Andreia Palmeira, Sofia Martins Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1171-1195
Closed Access | Times Cited: 18
A review on inflammation modulating venom proteins/peptide therapeutics and their delivery strategies: A review
Lakshmikanthan Hemajha, Simran Singh, Catherin Ann Biji, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113130-113130
Closed Access | Times Cited: 6
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Samo Ribarič
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4358-4358
Open Access | Times Cited: 5
Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands
Ferenc Bogár, Lívia Fülöp, Botond Penke
Biomolecules (2022) Vol. 12, Iss. 3, pp. 363-363
Open Access | Times Cited: 22
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
Bruno Dutra Arbo, Lúcia Emanueli Schimith, Michele Goulart dos Santos, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174800-174800
Open Access | Times Cited: 20
Non-steroidal Anti-inflammatory Drugs (NSAIDs) in Major Depressive Disorder (MDD) Treatment
Qian He, Adam N. Bennett, Kei Hang Katie Chan
(2025), pp. 1-22
Closed Access
Platelet inhibition delays cerebral metastasis in non-small cell lung cancer
David Wasilewski, Julia Onken, Sae‐Yeon Won, et al.
Research Square (Research Square) (2025)
Closed Access
Computational Analysis of Curcuma longa L Compounds: Unraveling Molecular Interactions and Drug-like Properties for Novel Therapeutic Applications
Oluwaseun E. Agboola, Samuel S. Agboola, Abimbola Fadugba, et al.
Next research. (2025), pp. 100283-100283
Closed Access
Discovery and optimization of ibuprofen derivatives as the NF-κB/iNOS pathway inhibitors for the treatment of ulcerative colitis
Chao Lin, Zhongsheng Li, Zhengqi Dong, et al.
Bioorganic Chemistry (2025) Vol. 161, pp. 108506-108506
Closed Access
Synthesis of Copper Oxide-Based Nanoformulations of Etoricoxib and Montelukast and Their Evaluation through Analgesic, Anti-Inflammatory, Anti-Pyretic, and Acute Toxicity Activities
Sulaiman Sulaiman, Shabir Ahmad, Syeda Sohaila Naz, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1433-1433
Open Access | Times Cited: 17
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
Isidró Ferrer
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 3
Closed Access | Times Cited: 16
PPARγ, NF-κB and the UPR pathway as new molecular targets in the anti-inflammatory actions of NSAIDs: Novel applications in cancers and central nervous system diseases?
Paulina Sokołowska, Layla Bleibel, Jacek Owczarek, et al.
Advances in Clinical and Experimental Medicine (2024) Vol. 33, Iss. 9, pp. 1007-1022
Open Access | Times Cited: 3
Investigating the therapeutic promise of Drug-Repurposed-Loaded Nanocarriers: A pioneering strategy in advancing colorectal cancer treatment
Amina Tarek Mneimneh, Nadine Darwiche, Mohammed M. Mehanna
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124473-124473
Closed Access | Times Cited: 3
Recent Advances in ROS-Scavenging Metallic Nanozymes for Anti-Inflammatory Diseases: A Review
Adityanarayan Mohapatra, In‐Kyu Park
Chonnam Medical Journal (2023) Vol. 59, Iss. 1, pp. 13-13
Open Access | Times Cited: 8
The effect of parecoxib sodium on postoperative delirium in elderly patients with hip arthroplasty
Jinhuo Wang, Tong Liu, Yu Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Synthesis, molecular docking and anti-inflammatory evaluation of new trisubstituted pyrazoline derivatives bearing benzenesulfonamide moiety
Ayad M.R. Raauf, Tagreed N-A Omar, Monther Faisal Mahdi, et al.
Natural Product Research (2022) Vol. 38, Iss. 2, pp. 253-260
Open Access | Times Cited: 10
Synthesis of zinc oxide based etoricoxib and montelukast nanoformulations and their evaluation through analgesic, anti-inflammatory, anti-pyretic and acute toxicity activities
Sulaiman Sulaiman, Shabir Ahmad, Syeda Sohaila Naz, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 4, pp. 101938-101938
Open Access | Times Cited: 9
Etoricoxib nanostructured lipid carriers attenuate inflammation by modulating Cyclooxygenase-2 signaling and activation of nuclear factor-κB-p65 pathways in radiation-induced acute cardiotoxicity in rats
Eman F. S. Taha, Noha Sayed Hamed, Sahar Khateeb
European Journal of Pharmacology (2023) Vol. 957, pp. 176029-176029
Closed Access | Times Cited: 4
A Combination of Pharmacophore Generation, Ligand-based Virtual Screening, Atom-based 3D-QSAR, and Molecular Docking Studies on Febuxostat-based Amides Analogues as Anti-inflammatory Agents
Trupti S. Chitre, Aniket L. Bhatambrekar, Purvaj V. Hirode, et al.
Current Drug Discovery Technologies (2024) Vol. 22, Iss. 1
Closed Access | Times Cited: 1
Path of Pyrazoles from Synthetic Factors to Anti-inflammatory Potential: A Review
Ketan Vashisht, Pooja Sethi, Anshul Bansal, et al.
Asian Journal of Chemistry (2024) Vol. 36, Iss. 6, pp. 1217-1231
Open Access | Times Cited: 1
A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database
Zhuohui Chen, Xiang Wang, Ziwei Teng, et al.
EBioMedicine (2024) Vol. 107, pp. 105314-105314
Open Access | Times Cited: 1
Novel drug-drug co-amorphous systems of olaparib with nonsteroidal anti-inflammatory drugs with improved solubility, physical stability, antitumor activity and pharmacokinetics
Zheng-Kang Luo, Hui‐Min Qin, Jin-Meng Han, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106232-106232
Closed Access | Times Cited: 1
Principles of effective use of non-steroidal anti-inflammatory drugs
Viktor Meretskyi, I. Meretska
Inter Collegas (2023) Vol. 10, Iss. 1, pp. 20-26
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top